In comparison to the control cells, the level of p-cyclin B1 (Ser133) was decreased 36.2% and 66.4% when treated with 1 and 5 μM ALS for 48 h, respectively (p < 0.01; Figure 3B and Figure S3B). The gene discussed is CCNB1; the disease is amyotrophic lateral sclerosis.